完全缓解

诱导治疗后4例完全缓解（CR），7例部分缓解（PR）。

After induction treatment 4 cases achieved complete response ( CR ) and 7 cases achieved partial response ( PR ) .

结果：新辅助化疗后，观察组术前肿瘤病灶临床完全缓解（CR）9例，部分缓解（PR）37例。

Results : In study group , after neoadjuvant chemotherapy , 9 cases achieved clinical complete response ( CR ) and37 cases achieved partial response ( PR ) .

结果24例患者完全缓解率（CR）83.3%。

Results Complete remission rate ( CR ) was 83.3 % .

试验组和对照组用药，达到完全缓解（CR）后停药。

Both groups stopped treatment on achieving complete remission ( CR ) .

结果32例膀胱癌完全缓解（CR）率为71.9%。

Results The complete regression rate among 32 cases of bladder cancer was 71.9 % .

完全缓解的一例，大核细胞数目增多，DNA含量趋向正态分布。

The number of large nucleus cells was increased , DNA content was toward to normal distribution ni one case with complete remission .

初步的临床研究结果显示，临床完全缓解（CR）率为34.4%，有效率62.5%。

Preliminary clinical finding demonstrates that clinical CR rate is 34.4 % , effective power rate is 62.5 % .

早期的研究成果发表在Blood上，研究人员发现神经酰胺脂质体在患有大颗粒淋巴细胞白血病的鼠中可以诱导侵袭性的完全缓解。

In an earlier study published in the journal Blood , researchers observed that cerasome use led to complete remission in aggressive , large granular lymphocytic leukemia in rats .

结果经新辅助化疗后，乳腺癌原发灶明显缩小，11%达到完全缓解（CR）；

Results After neoadjuvant chemotherapy , the primary cancer became smaller , 11 % of them was completely release ( CR );

其中经治疗完全缓解后的24例患儿，PA及肝功能其它值则均在正常范围。

PA and other liver functions tests in 24 cases with complete remission all recovered to normal .

结果总有效率（CR+PR）为72.2%，其中完全缓解（CR）2例，部分缓解（PR）11例。

Results The total response rate ( CR + PR ) was 72.2 % with 2 CR and 11 PR.

结果：完全缓解率100%，获CR所需的中位时间42.5d。

Result : Complete remission ( CR ) rate was 100 % . The mean time for achieving CR was 42.5 days .

完全缓解（CR）率为60%-80%，但50%-80%CR患者最终复发、耐药而成为难治性白血病。

Complete remission ( CR ) was60 % - 80 % , 50 % - 80 % CR patients eventually become relapsed .

结果：10例APL中完全缓解（CR）9例，CR率90%。

Results : Clinical complete remission ( CR ) was obtained in 9 cases ( 90 % ) .

老年白血病完全缓解（CR）率为23.9%，明显低于青壮年的53.7%。

Complete remission rate of elderly AL was 23.9 % , which was lower than that of young adults ' ( 53.7 % ) .

随访患者按实体瘤疗效标准：完全缓解（CR）4例，部分缓解（PR）17例，无变化（NC）2例，进展（PD）4例。

According to the criterion of curative effect of solid tumor follow-up CR4 patients , PR17 patients , NC2 patients and PD4 patients .

进展期霍奇金病经化疗达完全缓解后，巩固放疗的Meta分析

Meta-analysis of the effect of consolidation radiotherapy after complete remission in advanced Hodgkin 's disease following chemotherapy

AML一个疗程达到完全缓解的占90%。

The complete remission rate of AML was 90 % after one course of chemotherapy .

bcl－2、CD34高表达的急性白血病完全缓解率低，早期复发率高。

The CR rate in patients with overexpression of bcl-2 or CD34 was lower than were higher .

首程治疗后完全缓解（CR）率65.1%，先期化疗的CR率为34.4%。

Chemotherapy achieved a complete remission ( CR ) rate of 34.4 % for initial treatment , and of 65.1 % after primary treat - ment .

结果本组MG患者的临床完全缓解率为45.7%，死亡2例，与危象的发生无关，再住院率为5.7%。

A clinic complete remission rate in MG patients reached 45.7 % , readmission rate 5.7 % , 2 dead but not corresponding to the occurrence of crises .

治疗后获得完全缓解的患者，其NK活力与对照组无差异。

There was a similar mean value of NK activity in patients in complete remission , as compared with normal subjects .

结论：高剂量强度的VIP方案化疗能获得较高的有效率及完全缓解率，毒性能耐受。

Conclusion : The intensive VIP regimen can improve the efficacy of SCLC , and the toxicity was moderate .

AL和HD均在初次完全缓解后移植，ALC患者在化疗后获部分缓解后移植。

Transplantations were done after first complete remission for AL and HD patients , and for ALC after partial remission .

目的应用Meta分析的方法评价进展期霍奇金病经化疗达完全缓解后巩固放疗的作用。

Objective To perform a meta-analysis in reviewing consolidation radiotherapy after complete remission in advanced Hodgkin 's disease following chemotherapy .

目的：探讨早期强烈诱导缓解方案提高晚期淋巴母细胞性淋巴瘤的完全缓解（completeremission，CR）率。

Objective : This study was designed to improve complete remission ( CR ) rate in the patients with advanced lymphoblastic lymphoma by using early extensive induction chemotherapy .

将AL患者根据第一次化疗的疗效分为完全缓解（CR）组和未完全缓解（NR）组。

AL were divided into completely remission ( CR ) group and no completely remission ( NR ) depended on the reaction on first chemical therapy .

连续组和常规组有效率分别为90.0%（完全缓解20%，部分缓解70%）和43.8%（完全缓解6，3%，部分缓解37.5%），差异有非常显著性意义（P＝0.0039）。

Over-all response rates of continuous group were 90 % ( complete response 20 % , partial response 70 % ) and of conventional group were 43.8 % ( 6 . 3 % , 37.5 % ) .

而坚持巩固化疗组平均持续完全缓解期（19.8mo）明显长于对照组（8.4mo），统计学具有显著差异（P＜0.01）。

But the average period of unremitting complete relief in the group of keeping consolidating treatment was 19.8 months and the time was more longer than that of the control group ( 8.4 months , P < 0.01 ) .

结果：治疗组完全缓解率51.2%、总缓解率95.3%，对照组分别为25.9%和60.5%（P均<0.01）；

Results : The complete remission and the total relief rate were 51.2 % and 95.3 % in treatment group , meanwhile they were 25.9 % , and 60.5 % in control group ( all P < 0.01 ) .